Table 3.

The gap analysis model: criteria considered, levels within the criteria, scores and applied weighting coefficients (Coef)

Criteria	Scores					Coef	Total (score*coef)
Diagnostic tools	2	1	0	−1	−2	4.17	/100
1. Availability^a
2. Prevention and control - Differentiation of infected from vaccinated (DIVA)
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Affordable
7. Quality/stability durability
8. Sensitivity
9. Specificity
10. Reproducibility
11. Simplicity/ease of use
12. Speed
Vaccination tools	2	1	0	−1	−2	4.55	/100
1. Commercial availability^a
2. Monitoring for infection in a vaccinated population
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Affordable
7. Quality/stability
8. Safety of vaccines
9. Efficacy
10. Immunity
11. Convenience of use
Pharmaceutical tools	2	1	0	−1	−2	4.55	/100
1. Availability^a
2. Prevention and control
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Cost
7. Quality
8. Safety animal
9. Safety consumer/user concerns
10. Safety environment
11. Resistance
Total Score:

^aA maximum score of 20 was given to the whole criterion when there isn’t any product available (not even under development)